| Peritoneal Mesothelial Neoplasm studied in …STUDIED_INderived27 of 27show fewer |
|---|
| → studied in | NCT07277413Phase 1 · recruiting A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06057935Phase 2 · recruiting A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05001880Phase 2 · recruiting Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma · condition mapped ONTOLOGY_EXACT · 27 trials mapped (12 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped CURATED_BROADER · 27 trials mapped (12 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01617382recruiting Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04847063Phase 1 · recruiting Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02535312Phase 1/Phase 2 · active not recruiting Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin · condition mapped CURATED_BROADER · 27 trials mapped (12 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790706Phase 2 · active not recruiting IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07330271NA · recruiting PTC-Guided Therapy for Peritoneal Mesothelioma · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06756035Phase 1 · recruiting CT-95 in Advanced Cancers Associated With Mesothelin Expression · condition mapped CURATED_BROADER · 27 trials mapped (12 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02399371Phase 2 · completed Pembrolizumab in Treating Patients With Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 27 trials mapped (12 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05337735Phase 2 · suspended A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03875144Phase 2 · suspended Treatment of Malignant Peritoneal Mesothelioma (MESOTIP) · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05449366Phase 1/Phase 2 · completed Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma · condition mapped ONTOLOGY_EXACT · 27 trials mapped (12 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02040142Phase 2 · completed HIPEC for Peritoneal Carcinomatosis · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06543069Phase 2 · recruiting Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM · condition mapped CURATED_BROADER · 27 trials mapped (12 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03867578NA · completed Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05041062Phase 2 · completed A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05193006unknown Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 27 trials mapped (12 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03608618Phase 1 · terminated Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02151448Phase 1/Phase 2 · completed αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01592383Phase 2 · completed Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01160458Phase 2 · completed Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834169unknown French National Registry of Rare Peritoneal Surface Malignancies · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834234completed Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02588131Phase 2 · unknown A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1) · condition mapped ALIAS · 27 trials mapped (12 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |